These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4503867)

  • 21. Formation and persistence of neutralizing, complement-fixing and haemagglutination-inhibiting antibodies in Tahyna virus experimental infection of rabbits.
    Málková D; Kolman JM; Marhoul Z
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(4):482-92. PubMed ID: 5391989
    [No Abstract]   [Full Text] [Related]  

  • 22. A community study of respiratory infections in the tropics. II. The spread of six rhinovirus isolates within the community.
    Monto AS; Johnson KM
    Am J Epidemiol; 1968 Jul; 88(1):55-68. PubMed ID: 4298480
    [No Abstract]   [Full Text] [Related]  

  • 23. OC43 strain-related coronavirus antibodies in different age groups.
    Hovi T; Kainulainen H; Ziola B; Salmi A
    J Med Virol; 1979; 3(4):313-20. PubMed ID: 113504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a new infectious bronchitis virus isolate. I. Serological and pathogenicity studies of Clark 333.
    Cowen BS; Hitchner SB; Lucio B
    Avian Dis; 1971; 15(3):518-26. PubMed ID: 4938694
    [No Abstract]   [Full Text] [Related]  

  • 25. [Presence of antibodies to coronaviruses in sera of inhabitants of the UUSR].
    Zakstel'skaia LIa; Sheboldov AV; Vasil'eva VI; Alekseenkova LI
    Vopr Virusol; 1972; 17(2):161-5. PubMed ID: 5028026
    [No Abstract]   [Full Text] [Related]  

  • 26. Reactivity of human coronavirus OC43 and neonatal calf diarrhoea coronavirus membrane-associated antigens.
    Gerna G; Battaglia M; Cereda PM; Passarani N
    J Gen Virol; 1982 Jun; 60(Pt 2):385-90. PubMed ID: 7050300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of neutralizing, haemagglutination-inhibiting and strain-specific complement-fixing antibodies in guinea pigs given inactivated influenza vaccine.
    Závadová H; Vonka V
    Acta Virol; 1968 Mar; 12(2):151-6. PubMed ID: 4384403
    [No Abstract]   [Full Text] [Related]  

  • 28. The production of neutralizing activity in serum and nasal secretion following immunization with influenza B virus.
    Downie JC; Stuart-Harris CH
    J Hyg (Lond); 1970 Jun; 68(2):233-44. PubMed ID: 5270204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of respiratory viruses in personnel at an Antarctic base.
    Holmes MJ; Allen TR; Bradburne AF; Stott EJ
    J Hyg (Lond); 1971 Jun; 69(2):187-99. PubMed ID: 5282923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attempt to identify the agent for Creutzfeldt-Jakob disease by CF antibody relationship to known viruses.
    Brown P; Hooks J; Roos R; Gajdusek DC; Gibbs CJ
    Nat New Biol; 1972 Feb; 235(57):149-52. PubMed ID: 4333969
    [No Abstract]   [Full Text] [Related]  

  • 32. [VIRUS ANTIGEN ANTISERUM FOR DIAGNOSTIC USE].
    ARAI H
    Sogo Rinsho; 1964 Jul; 13():1230-3. PubMed ID: 14178419
    [No Abstract]   [Full Text] [Related]  

  • 33. Hemagglutination-inhibiting, complement-fixing and neutralizing antibody responses in ECHO 6 infection, including studies on heterotypic responses.
    BUSSELL RH; KARZON DT; BARRON AL; HALL FT
    J Immunol; 1962 Jan; 88():47-54. PubMed ID: 13875157
    [No Abstract]   [Full Text] [Related]  

  • 34. Visna and maedi virus antigen in infected cell cultures studied by the fluorescent antibody technique.
    Thormar H
    Acta Pathol Microbiol Scand; 1969; 75(2):296-302. PubMed ID: 4898521
    [No Abstract]   [Full Text] [Related]  

  • 35. Hemagglutination-inhibition tests with different strains of equine infectious anemia virus.
    Sentsui H; Kono Y
    Am J Vet Res; 1981 Nov; 42(11):1949-52. PubMed ID: 6175255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The platelet aggregation test (PA) as an immunological method in virology.
    Penttinen K; Myllylä G; Vaheri A; Vesikari T; Kääriäinen L
    Prog Immunobiol Stand; 1970; 4():672-5. PubMed ID: 5529808
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. II. Clinical reactions, hemagglutination-inhibitiong and strain and type-specific complement-fixing antibody responses in infants.
    Závadová H; Adam E; Vonka V; Domorázková E; Kratochvílová M; Burian V; Davenport FM
    Arch Gesamte Virusforsch; 1972; 36(1):53-61. PubMed ID: 5062439
    [No Abstract]   [Full Text] [Related]  

  • 38. Virological examination of bovine mammary lymph nodes.
    Woods GT; Mansfield ME; Krone J
    Can J Comp Med; 1970 Oct; 34(4):354-5. PubMed ID: 4320206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement-fixing and virus-neutralizing antibodies in cytomegalovirus infection as measured against homologous and heterologous antigen.
    Andersen HK
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1970; 78(4):504-8. PubMed ID: 4320956
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunizing effect of different cleavage products from influenza viruses].
    Lange FC
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):390-1. PubMed ID: 5523686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.